Charles McClure Net Worth

The estimated Net Worth of Charles G Mcclure is at least $1.77 Million dollars as of 4 January 2024. Mr. Mcclure owns over 1,572 units of 3D Systems stock worth over $5,633 and over the last 13 years he sold DDD stock worth over $1,360,605. In addition, he makes $400,000 as Independent Chairman of the Board at 3D Systems.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Mr. McClure DDD stock SEC Form 4 insiders trading

Charles has made over 10 trades of the 3D Systems stock since 2011, according to the Form 4 filled with the SEC. Most recently he exercised 1,572 units of DDD stock worth $3,443 on 4 January 2024.

The largest trade he's ever made was selling 71,695 units of 3D Systems stock on 4 December 2012 worth over $313,307. On average, Charles trades about 3,304 units every 93 days since 2011. As of 4 January 2024 he still owns at least 2,572 units of 3D Systems stock.

You can see the complete history of Mr. Mcclure stock trades at the bottom of the page.

Charles McClure biography

Charles G. McClure is an Independent Chairman of the Board of the 3D Systems Corporation. Mr. McClure has served as Chairman of the Board of Directors of the Company since October 2018. Mr. McClure has served as a Managing Partner of Michigan Capital Advisors since 2014 and has more than 35 years of experience in the transportation industry. Prior to founding Michigan Capital Advisors, Mr. McClure served as Chairman of the Board, Chief Executive Officer and President of Meritor, Inc. from 2004 through 2013. From 2002 through 2004, Mr. McClure served as Chief Executive Officer, President and a member of the Board of Federal Mogul Corp. Mr. McClure joined Federal Mogul in 2001 as president, Chief Operating Officer and a member of the Board. Before joining Federal Mogul, Mr. McClure served as President, Chief Executive Officer and a member of the Board of Detroit Diesel. He joined Detroit Diesel in 1997 after 14 years in a variety of management positions with Johnson Controls.Other Current Public Directorships: DTE Energy, a publicly traded Detroit-based energy company (since 2012), and Crane Corporation, a publicly traded industrial products company (since 2017). Prior Public Company Directorships (within the last five years): Remy International, Inc., a manufacturer and distributor of starters and alternators prior to its acquisition by BorgWarner Inc. (2015). Other Directorships, Trusteeships and Memberships: Member of the Board of Penske Corporation; Member of the Board of Trustees of Henry Ford Health Systems; Member of the Board of Directors of Invest Detroit; and Member of the Business Leaders for Michigan.

What is the salary of Charles McClure?

As the Independent Chairman of the Board of 3D Systems, the total compensation of Charles McClure at 3D Systems is $400,000. There are 7 executives at 3D Systems getting paid more, with Herbert Koeck having the highest compensation of $1,443,180.

How old is Charles McClure?

Charles McClure is 66, he's been the Independent Chairman of the Board of 3D Systems since 2018. There are 6 older and 20 younger executives at 3D Systems. The oldest executive at 3D Systems Corp. is Dr. Charles W. Hull, 81, who is the Co-Founder, Exec. VP, CTO of Regenerative Medicine & Director.

What's Charles McClure's mailing address?

Charles's mailing address filed with the SEC is 333, Three D Systems Circle, Rock Hill, York County, South Carolina, 29730, United States.

Insiders trading at 3D Systems

Over the last 14 years, insiders at 3D Systems have traded over $140,581,615 worth of 3D Systems stock and bought 532,605 units worth $6,075,291 . The most active insiders traders include G Walter Ii Loewenbaum, Abraham N Reichental, and Vyomesh Joshi. On average, 3D Systems executives and independent directors trade stock every 25 days with the average trade being worth of $60,930. The most recent stock trade was executed by Thomas W Erickson on 28 November 2023, trading 50,000 units of DDD stock currently worth $265,000.

What does 3D Systems do?

3d systems provides the most advanced and comprehensive 3d digital design and fabrication solutions available today, including 3d printers, print materials and cloud-sourced custom parts. its powerful ecosystem transforms entire industries by empowering professionals and consumers everywhere to bring their ideas to life using its vast material selection, including plastics, metals, ceramics and edibles. 3ds’ leading personalized medicine capabilities save lives and include end-to-end simulation, training and planning, and printing of surgical instruments and devices for personalized surgery and patient specific medical and dental devices. its democratized 3d digital design, fabrication and inspection products provide seamless interoperability and incorporate the latest immersive computing technologies. 3ds’ products and services disrupt traditional methods, deliver improved results and empower its customers to manufacture the future now.

Complete history of Mr. Mcclure stock trades at 3D Systems, Crane Co, DTE Co, and Meritor Inc

3D Systems executives and stock owners

3D Systems executives and other stock owners filed with the SEC include:

• Herbert Koeck,
  Executive Vice President, Global Go To Market
• Andrew Johnson,
  Executive Vice President, Chief Legal Officer and Secretary
• Dr. Jeffrey A. Graves,
  Pres, CEO & Director
• Reji Puthenveetil,
  Exec. VP of Industrial Solutions
• Charles Hull,
  Chief Technology Officer, Executive Vice President, Director
• Menno Ellis,
  Exec. VP of Healthcare Solutions
• Andrew Martin Johnson,
  Exec. VP, Chief Legal Officer & Sec.
• Charles McClure,
  Independent Chairman of the Board
• Thomas Erickson,
  Independent Director
• William Curran,
  Independent Director
• Kevin Moore,
  Independent Director
• John Tracy,
  Independent Director
• William Humes,
  Independent Director
• Jeffrey Wadsworth,
  Independent Director
• Jimmy Kever,
  Independent Director
• Malissia Clinton,
  Independent Director
• Anthony Grabenau,
  Principal Accounting Officer
• Sadie Stern,
  Executive Vice President - People and Culture
• Reji Puthenveetil,
  Executive Vice President - Industrial Solutions
• Radhika Krishnan,
  Executive Vice President - Software and Healthcare
• Menno Ellis,
  Executive Vice President - Healthcare Solutions
• Jagtar Narula,
  Chief Financial Officer, Executive Vice President
• Jeffrey Graves,
  President, Chief Executive Officer, Executive Director
• Phyllis B. Nordstrom,
  Exec. VP, Chief People & Culture Officer and Chief Compliance Officer
• John E. Nypaver Jr.,
  VP of Investor Relations & Treasurer
• Dr. Brent Stucker Ph.D.,
  Chief Scientist
• Michael S. Crimmins,
  Sr. VP & Chief Accounting Officer
• Dr. Charles W. Hull,
  Co-Founder, Exec. VP, CTO of Regenerative Medicine & Director
• Jeff Blank,
  Exec. VP of Engineering & Product Devel.
• Allen Latty,
  Sr. VP of People & Culture
• Anthony J. Grabenau,
  VP, Global Corp. Controller & Principal Accounting Officer
• Jagtar Narula,
  Exec. VP & CFO
• Jeffrey D Creech,
  EVP & CFO
• Jim D Kever,
  Director
• John N Mc Mullen,
  EVP & CFO
• Kevin Mcalea,
  Vice President
• G Walter Ii Loewenbaum,
  Director
• Karen E Welke,
  Director
• Mark William Wright,
  EVP & COO
• Vyomesh Joshi,
  President and CEO
• Cathy L Lewis,
  Vice President
• Riper Daniel S Van,
  Director
• Andrew William Banasick Wright,
  SVP, GC & Secretary
• Vasant Padmanabhan,
  Director
• Joseph R. Zuiker,
  EVP, Engineering & Operations
• Philip C. Schultz,
  EVP, Operations
• Theodore A Hull,
  EVP & CFO on 11-11-2014
• Abraham N Reichental,
  President and CEO
• Peter Diamandis,
  Director
• David Robert Styka,
  VP & Chief Accounting Officer
• Damon Joseph Gregoire,
  VP, Chief Financial Officer
• Robert M Jr Grace,
  VP, General Counsel & Secretar
• Todd Booth,
  EVP & Chief Financial Officer
• Michael S Crimmins,
  Former SVP and CAO
• Wayne C Pensky,
  Interim CFO
• Jeff Blank,
  EVP, Engineering and Prod Dev
• David K Leigh,
  EVP & CTO (Additive Mfg)
• Phyllis B Nordstrom,
  EVP & CHRO
• Claudia Drayton,
  Director
• Michael Lynn Turner,
  
• Harriss T Currie,
  President, Regenerative Med
• Margaret E Wicklund,
  Chief Accounting Officer